Bioanalytical Systems (BASI) Upgraded to C at TheStreet

Bioanalytical Systems (NASDAQ:BASI) was upgraded by research analysts at TheStreet from a “d+” rating to a “c” rating in a research note issued to investors on Wednesday.

Bioanalytical Systems opened at $1.66 on Wednesday, Marketbeat.com reports. Bioanalytical Systems has a 1 year low of $1.76 and a 1 year high of $1.83. The company has a current ratio of 0.72, a quick ratio of 0.59 and a debt-to-equity ratio of 0.53.

Bioanalytical Systems (NASDAQ:BASI) last released its quarterly earnings data on Tuesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $5.94 million during the quarter. Bioanalytical Systems had a return on equity of 6.39% and a net margin of 2.35%.

Several large investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its position in shares of Bioanalytical Systems by 80.6% during the 4th quarter. Renaissance Technologies LLC now owns 244,200 shares of the company’s stock worth $598,000 after acquiring an additional 109,000 shares in the last quarter. Deutsche Bank AG boosted its position in shares of Bioanalytical Systems by 194.1% during the 4th quarter. Deutsche Bank AG now owns 59,400 shares of the company’s stock worth $145,000 after acquiring an additional 39,200 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its position in shares of Bioanalytical Systems by 240.2% during the 4th quarter. Acadian Asset Management LLC now owns 45,375 shares of the company’s stock worth $111,000 after acquiring an additional 32,039 shares in the last quarter. 11.05% of the stock is owned by institutional investors and hedge funds.

About Bioanalytical Systems

Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments.

Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply